Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript

EXAS earnings call for the period ending December 31, 2023.

Related Keywords

Seattle ,Washington ,United States ,Italy ,Phoenix ,Arizona ,New York ,Japan ,Germany ,Canada ,San Diego ,California ,Americans ,Matt Sykes ,Brandon Couillard Jefferies ,Subbu Nambi Guggenheim ,Andrew Brackmann William Blair ,Jeff Elliott ,Kevin Conroy ,Brandon Couillard ,Vijay Kumar Evercore ,Puneet Souda ,Dan Brennan ,Subbu Nambi ,Andrew Cooper ,Doug Schenkel ,Everett Cunningham ,Puneet Souda Leerink ,Patrick Donnelly Citi ,Andrew Cooper Raymond James ,Raymond James ,Brian Baranick ,Mark Massaro ,William Blair ,Dan Leonard ,Vijay Kumar ,Matt Sykes Goldman Sachs ,Jack Meehan ,Andrew Brackmann ,Nate Harrill ,Dan Arias ,Patrick Donnelly ,Catherine Schulte ,Wolfe Research ,Nephron Research ,Dan Arias Stifel Financial Corp ,Goldman Sachs ,Broad Institute ,Jack Meehan Nephron Research Analyst ,Doug Schenkel Wolfe Research Analyst ,Company Analyst ,Exact Sciences ,Exact Science ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Chief Operating ,New Year ,Labor Day ,Resolution Bioscience ,Medicare Advantage ,Precision Oncology ,New York State ,Chief Commercial ,Stifel Financial ,General Manager ,Leerink Partners ,Guggenheim Partners ,Chief Executive Officer ,